Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.
2.

Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer.

Lee CH, Zhang JF, Yuan KS, Wu ATH, Wu SY.

Strahlenther Onkol. 2019 Jan 28. doi: 10.1007/s00066-019-01428-7. [Epub ahead of print]

PMID:
30690687
3.

Antrocin, a bioactive component from Antrodia cinnamomea, suppresses breast carcinogenesis and stemness via downregulation of β-catenin/Notch1/Akt signaling.

Chen JH, T H Wu A, T W Tzeng D, Huang CC, Tzeng YM, Chao TY.

Phytomedicine. 2019 Jan;52:70-78. doi: 10.1016/j.phymed.2018.09.213. Epub 2018 Sep 27.

PMID:
30599914
4.

Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery.

Qin L, Chen TM, Kao YW, Lin KC, Yuan KS, Wu ATH, Shia BC, Wu SY.

Cancers (Basel). 2018 Oct 22;10(10). pii: E392. doi: 10.3390/cancers10100392.

5.

Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues.

Yu HH, Chengchuan Ko E, Chang CL, Yuan KS, Wu ATH, Shan YS, Wu SY.

Mar Drugs. 2018 Oct 19;16(10). pii: E392. doi: 10.3390/md16100392.

6.

Destruxin B Suppresses Drug-Resistant Colon Tumorigenesis and Stemness Is Associated with the Upregulation of miR-214 and Downregulation of mTOR/β-Catenin Pathway.

Wu SY, Huang YJ, Tzeng YM, Huang CF, Hsiao M, Wu ATH, Huang TH.

Cancers (Basel). 2018 Sep 25;10(10). pii: E353. doi: 10.3390/cancers10100353.

7.

Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study.

Lin YK, Hsieh MC, Chang CL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2018 Nov;129(2):326-332. doi: 10.1016/j.radonc.2018.07.012. Epub 2018 Aug 3.

PMID:
30082144
8.

Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study.

Qin L, Kao YW, Lin YL, Peng BY, Deng WP, Chen TM, Lin KC, Yuan KS, Wu ATH, Shia BC, Wu SY.

Cancer Med. 2018 Aug;7(8):4104-4114. doi: 10.1002/cam4.1685. Epub 2018 Jul 15.

9.

Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.

Liu M, Bamodu OA, Kuo KT, Lee WH, Lin YK, Wu ATH, M H, Tzeng YM, Yeh CT, Tsai JT.

Am J Chin Med. 2018;46(4):891-910. doi: 10.1142/S0192415X18500477. Epub 2018 May 24.

PMID:
29792038
10.

Efficacy of thoracic radiotherapy in patients with stage IIIB-IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment.

Yen YC, Hsu HL, Chang JH, Lin WC, Chang YC, Chang CL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2018 Oct;129(1):52-60. doi: 10.1016/j.radonc.2018.03.007. Epub 2018 Apr 24.

PMID:
29703499
11.

Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways.

Fann LY, Chen Y, Chu DC, Weng SJ, Chu HC, Wu ATH, Lee JF, Ali AAA, Chen TC, Huang HS, Ma KH.

Oncotarget. 2017 Dec 27;9(15):11922-11937. doi: 10.18632/oncotarget.23714. eCollection 2018 Feb 23.

12.

Transcriptome analysis and prognosis of ALDH isoforms in human cancer.

Chang PM, Chen CH, Yeh CC, Lu HJ, Liu TT, Chen MH, Liu CY, Wu ATH, Yang MH, Tai SK, Mochly-Rosen D, Huang CF.

Sci Rep. 2018 Feb 9;8(1):2713. doi: 10.1038/s41598-018-21123-4.

13.

BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas.

Huang SP, Chang YC, Low QH, Wu ATH, Chen CL, Lin YF, Hsiao M.

Oncotarget. 2017 Nov 27;8(69):113766-113791. doi: 10.18632/oncotarget.22667. eCollection 2017 Dec 26.

14.

Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.

Chang CL, Tsai HC, Lin WC, Chang JH, Hsu HL, Chow JM, Yuan KS, Wu ATH, Wu SY.

Radiother Oncol. 2017 Oct;125(1):73-79. doi: 10.1016/j.radonc.2017.08.025. Epub 2017 Sep 17.

PMID:
28923576
15.

Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes.

Chang JH, Wu CC, Yuan KS, Wu ATH, Wu SY.

Oncotarget. 2017 Mar 17;8(33):55600-55612. doi: 10.18632/oncotarget.16340. eCollection 2017 Aug 15.

16.

Long noncoding RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer progression.

Shih JW, Chiang WF, Wu ATH, Wu MH, Wang LY, Yu YL, Hung YW, Wang WC, Chu CY, Hung CL, Changou CA, Yen Y, Kung HJ.

Nat Commun. 2017 Jun 22;8:15874. doi: 10.1038/ncomms15874.

17.

Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.

Chang YC, Chan YC, Chang WM, Lin YF, Yang CJ, Su CY, Huang MS, Wu ATH, Hsiao M.

Cancer Lett. 2017 Sep 10;403:28-36. doi: 10.1016/j.canlet.2017.06.001. Epub 2017 Jun 10.

PMID:
28610954
18.

Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.

Lin WC, Ding YF, Hsu HL, Chang JH, Yuan KS, Wu ATH, Chow JM, Chang CL, Chen SU, Wu SY.

Cancer. 2017 Oct 15;123(20):3904-3915. doi: 10.1002/cncr.30823. Epub 2017 Jun 13.

19.

Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression.

Su YK, Shih PH, Lee WH, Bamodu OA, Wu ATH, Huang CC, Tzeng YM, Hsiao M, Yeh CT, Lin CM.

J Ethnopharmacol. 2017 Jul 31;207:47-56. doi: 10.1016/j.jep.2017.06.004. Epub 2017 Jun 8.

PMID:
28602756
20.

4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.

Liu M, Bamodu OA, Huang WC, Zucha MA, Lin YK, Wu ATH, Huang CC, Lee WH, Yuan CC, Hsiao M, Deng L, Tzeng YM, Yeh CT.

Toxicol Appl Pharmacol. 2017 Jun 15;325:48-60. doi: 10.1016/j.taap.2017.04.003. Epub 2017 Apr 10.

PMID:
28408137

Supplemental Content

Loading ...
Support Center